AstraZeneca

Candidate Targets Indication Partner Our Commercial
Rights
Discovery Preclinical IND-
enabling
Phase I Phase Ib/IIa
AstraZeneca 4 Programs n.d. Respiratory Diseases U.S. Co-commercialization for 2 targets
Discovery Phase in progress
Pre-Clinical Phase not started
IND-enabling Phase not started
Phase 1 not started
Phase 2 not started